Title | Credits | Start date - Expiration date |
---|---|---|
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors | 1.75 | 08/09/2023 - 12:00am to 08/09/2024 - 12:00am |
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 2.00 | 12/21/2023 - 12:00am to 12/21/2024 - 12:00am |